Category: Clinical Research

Home / Clinical Research
LPNV201: Treatment of Chemo Induced Nausea/Vomiting
Post

LPNV201: Treatment of Chemo Induced Nausea/Vomiting

A Randomized, Dose-ranging, Open-label, Parallel Group Study to Assess the Efficacy, Safety and Pharmacokinetics of Palonosetron HCl Buccal Film versus IV Palonosetron 0.25 mg (ALOXI®) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Receiving Moderately Emetogenic Chemotherapy Not all clinical research we do here at the Gettysburg Cancer Center is specifically for...

Treatment of Chemo Induced Myelosuppression
Post

Treatment of Chemo Induced Myelosuppression

A Phase 3 Randomized, Double-blind Trial of Trilaciclib versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer Some cancer treatments can suppress the production blood cells that we need to be healthy. One such cancer treatment used to treat colorectal cancer is a regimen that uses a combination of folinic acid (leucovorin), fluorouracil (5FU),...

Lung Cancer Genomic Testing (EGFR, KRAS, ALK)
Post

Lung Cancer Genomic Testing (EGFR, KRAS, ALK)

Medical oncologist Marc Kris has been a key player in helping bring personalized medicine to people with lung cancer. He leads a research team working to find new genetic targets in cancer cells and to test anticancer medicines that specifically attack the lung cancers driven by these molecular changes.

Patient Information on Clinical Studies
Post

Patient Information on Clinical Studies

Mission Statement For over a quarter of a century The Gettysburg Cancer Center has been committed to providing cancer care in a community-based setting close to home. Our all-encompassing oncology and hematology programs provide a complete range of diagnosis, treatment, and follow-up care. Our caring and educated staff remains dedicated to providing insightful, compassionate care...

Merck Study – Head and neck squamous cell carcinoma
Post

Merck Study – Head and neck squamous cell carcinoma

A Phase 2, randomized, open-label three-arm clinical study to evaluate the safety and efficacy of lenvatinib (E7080/MK-7902) in combination with pembrolizumab (MK-3475) versus standard of care chemotherapy and lenvatinib monotherapy in participants with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) that have progressed after platinum therapy and immunotherapy (PD-1/PD-L1 inhibitors) (LEAP-009) We are...

BASKET Study – Covers multiple solid tumor cancer types
Post

BASKET Study – Covers multiple solid tumor cancer types

An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) This study is designed to treat multiple solid tumor cancers. This type of study is done because of how the drug is expected to work against cancer. This study will enroll...

QUILT 2.023 Study – Lung Cancer
Post

QUILT 2.023 Study – Lung Cancer

QUILT-2.023: A PHASE 3, OPEN-LABEL, 3-COHORT RANDOMIZED STUDY OF N-803 IN COMBINATION WITH CURRENT STANDARD OF CARE VS STANDARD OF CARE AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) Lung cancer begins in the lungs and most often occurs in people who smoke. While this is a very simple...

Zeno Study – Lung Cancer
Post

Zeno Study – Lung Cancer

A Phase I/2 Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of ZN-e4 (KP-673) in Patients with Advanced Non-Small Cell Lung Cancer with activating Epidermal Growth Factor Receptor (EGFR) mutations The cells in our bodies are constantly dividing to create new cells and new tissue. This division requires the cell...

Finding New Solutions in the Fight Against Cancer Through Research
Post

Finding New Solutions in the Fight Against Cancer Through Research

While the most overt cancer research news usually comes from efforts to derail the progression of the deadly disease, research into the development of alternative pathways to finding an ultimate solution to cancer often go unnoticed or fail to receive the same level of notice among the public. Advances are being made in new techniques...

Cancer Research: Not Always an Exact Science
Post

Cancer Research: Not Always an Exact Science

It is the question most frequently asked of doctors by patients who have just received a diagnosis of cancer, “Why me?” It is usually asked by those who thought they were living a healthy lifestyle and had little expectation of receiving the devastating news. Others may have been aware of near or distant family members...